Cargando…
Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells
Per- and polyfluoroalkyl substances (PFASs) are omnipresent and have been shown to induce a wide range of adverse effects, including hepatotoxicity, developmental toxicity and immunotoxicity. So far, little information is available about the mechanisms underlying the toxicity of PFASs, including tho...
Autores principales: | Janssen, Aafke W. F., Louisse, Jochem, Rijkers, Deborah, Pinckaers, Nicole E. T., Hoekstra, Sjoerdtje A., Hoogenboom, Ron L. A. P., Peijnenburg, Ad A. C. M., Beekmann, Karsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859925/ https://www.ncbi.nlm.nih.gov/pubmed/36326898 http://dx.doi.org/10.1007/s00204-022-03405-z |
Ejemplares similares
-
Determination of in vitro hepatotoxic potencies of a series of perfluoroalkyl substances (PFASs) based on gene expression changes in HepaRG liver cells
por: Louisse, Jochem, et al.
Publicado: (2023) -
Perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), and perfluorononanoic acid (PFNA) increase triglyceride levels and decrease cholesterogenic gene expression in human HepaRG liver cells
por: Louisse, Jochem, et al.
Publicado: (2020) -
Perfluoroalkyl substances (PFASs) are substrates of the renal human organic anion transporter 4 (OAT4)
por: Louisse, Jochem, et al.
Publicado: (2022) -
New approach methodologies: A quantitative in vitro to in vivo extrapolation case study with PFASs
por: Fragki, Styliani, et al.
Publicado: (2023) -
Bioassay-directed analysis-based identification of relevant pyrrolizidine alkaloids
por: Louisse, Jochem, et al.
Publicado: (2022)